CLINICAL_TRIALS ClinicalTrials.gov record with results posted

A Phase II Clinical Trial Evaluating the Combination of Onapristone With Anastrozole for Women With Refractory Hormone Receptor Positive Endometrial Cancer

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT04719273
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-07-18T00:04:12.224509+00:00
Published At: 2026-07-17T00:00:00+00:00
Record Updated At: 2026-07-17
Results Posted At: 2026-07-17
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["Refractory Endometrial Adenocarcinoma", "Refractory Endometrial Carcinoma", "Refractory Endometrial Clear Cell Adenocarcinoma", "Refractory Endometrial Endometrioid Adenocarcinoma", "Refractory Endometrial Mixed Cell Adenocarcinoma", "Refractory Endometrial Serous Adenocarcinoma", "Refractory Endometrial Undifferentiated Carcinoma"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2026-07-17"
protocolSection.identificationModule.nctId: "NCT04719273"
protocolSection.identificationModule.officialTitle: "A Phase II Clinical Trial Evaluating the Combination of Onapristone With Anastrozole for Women With Refractory Hormone Receptor Positive Endometrial Cancer"
protocolSection.statusModule.overallStatus: "COMPLETED"
protocolSection.designModule.phases: ["PHASE2"]
protocolSection.statusModule.resultsFirstPostDateStruct.date: "2026-07-17"

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.